Profile
John J.
Turanin was the founder who founded Zogenix, Inc. in 2006 and held the title of Vice President & General Manager in 2013.
He worked as General Manager-Operations, Quality & Marketing at Invacare Corp.
from 1987 to 1996 and as VP-Program Management & Corporate Planning at Aradigm Corp.
from 1997 to 2006.
Mr. Turanin holds an MBA degree from the University of Pittsburgh and an undergraduate degree from Indiana University of Pennsylvania.
Former positions of John J. Turanin
| Companies | Position | End |
|---|---|---|
| ARADIGM CORPORATION | Corporate Officer/Principal | 2006-03-31 |
| INVACARE CORPORATION | Chief Operating Officer | 1995-12-31 |
| ZOGENIX, INC. | Founder | - |
Training of John J. Turanin
| University of Pittsburgh | Masters Business Admin |
| Indiana University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Invacare Corp.
 Invacare Corp. Medical SpecialtiesHealth Technology Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- John J. Turanin